2025 HCPCS Code Q0245
Injection, bamlanivimab and etesevimab, 2100 mg
TAGS: bamlanivimab| Notice | HCPCS Q0245 terminated on December 13, 2023. |
| Short Description | Bamlanivimab and etesevima |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | February 09, 2021 |
| HCPCS Action Effective Date | December 14, 2023 |
| HCPCS Pricing Indicator Code | 54 - Vaccinations |
| HCPCS Type Of Service Code | V - Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95 |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q0502 - Mobility cart pneum vad, rep
- Q0503 - Battery pneum vad replacemnt
- Q0504 - Pwr adpt pneum vad, rep veh
- Q0506 - Lith-ion batt elec/pneum vad
- Q0507 - Misc sup/acc ext vad
- Q0508 - Mis sup/acc imp vad
- Q0509 - Mis sup/ac imp vad nopay med
- Q0510 - Dispens fee immunosupressive
- Q0511 - Sup fee antiem,antica,immuno
- Q0512 - Px sup fee anti-can sub pres
- Q0513 - Disp fee inhal drugs/30 days
- Q0514 - Disp fee inhal drugs/90 days
- Q0515 - Sermorelin acetate injection
- Q0516 - Supply fee hiv prep oral 30
- Q0517 - Supply fee hiv prep oral 60
- Q0518 - Supply fee hiv prep oral 90
- Q0519 - Supply fee hiv prep inj 30
- Q0520 - Supply fee hiv prep inj 60
- Q0521 - Supply fee hiv prep fda appr
- Q1004 - Ntiol category 4
